Search results for "RICH PLASMA"

showing 10 items of 50 documents

Quantification of growth factors by using a new system for obtaining platelet-rich plasma

2010

Objective: To verify the performance of a new method for obtaining platelet-rich plasma, while avoiding contami- nation of the sample during its processing. Study Design: Twenty healthy patients were selected, from whom 21 ml of blood was etracted. �e then pro- Design: Twenty healthy patients were selected, from whom 21 ml of blood was etracted. �e then pro- esign: Twenty healthy patients were selected, from whom 21 ml of blood was etracted. �e then pro- ceeded to study the platelets and growth factors in basal blood after centrifuging the sample by using a new closed system for obtaining platelet-rich plasma (PRP). Results: After centrifuging the blood sample, double the amount of platelet…

ChemistryPlatelet-Rich PlasmaGrowth factormedicine.medical_treatmentInsulinCentrifugationHematology:CIENCIAS MÉDICAS [UNESCO]AndrologyYoung AdultOtorhinolaryngologyBasal (medicine)Platelet-rich plasmaImmunologyUNESCO::CIENCIAS MÉDICASmedicineHumansIntercellular Signaling Peptides and ProteinsSurgeryPlateletPlatelet concentrateSistema circulatorioGeneral DentistryTransforming growth factor
researchProduct

Platelet-Rich Plasma (PRP) in Dental Extraction of Patients at Risk of Bisphosphonate-Related Osteonecrosis of the Jaws: A Two-Year Longitudinal Study

2020

: Dental extraction has often been described as the main trigger event of osteonecrosis of the jaws (ONJ). This longitudinal hospital-based study aimed to evaluate the outcome at 2 years of a standardized medical-surgical protocol for dental extraction, combined with platelet rich-plasma (PRP) application, compared with conventional protocol not combined with PRP or any other autologous platelet concentrate in cancer (ONC) and osteometabolic (OST) patients, at risk of bisphosphonate (BP)-related ONJ. Twenty patients were consecutively recruited: six received BPs for cancer skeletal-related events (34.17 &plusmn

Longitudinal studymedicine.medical_specialtybisphosphonatePRPmedicine.medical_treatmentONJosteonecrosis of the jawslcsh:TechnologyMetabolic bone diseaselcsh:Chemistry03 medical and health sciences0302 clinical medicineSettore MED/28 - Malattie OdontostomatologicheInternal medicinemedicineGeneral Materials ScienceAutologous plateletProspective cohort studyInstrumentationbisphosphonateslcsh:QH301-705.5Fluid Flow and Transfer Processesbusiness.industrylcsh:TProcess Chemistry and TechnologyGeneral EngineeringCancerplatelet-rich plasma030206 dentistryBisphosphonatemedicine.diseaselcsh:QC1-999Computer Science Applicationsosteonecrosis of the jawDental extractionlcsh:Biology (General)lcsh:QD1-999lcsh:TA1-2040030220 oncology & carcinogenesisPlatelet-rich plasmadental extractionbusinesslcsh:Engineering (General). Civil engineering (General)lcsh:PhysicsApplied Sciences
researchProduct

Comprehensive platelet phenotyping supports the role of platelets in the pathogenesis of acute venous thromboembolism - results from clinical observa…

2020

Background: The pathogenesis of arterial and venous thrombosis is in large part interlaced. How much platelet phenotype relates to acute venous thromboembolism (VTE) independent of the underlying cardiovascular profile is presently poorly investigated.Methods: Platelet count and mean platelet volume (MPV), platelet aggregation in whole blood and platelet rich plasma (PRP), platelet-dependent thrombin generation (TG) and platelet surface activation markers were measured under standardized conditions. Machine learning was applied to identify the most relevant characteristics associated with VTE from a large array (N = 58) of clinical and plateletrelated variables.Findings: VTE cases (N = 159)…

Male0301 basic medicinePlatelet Aggregationlcsh:MedicineDETERMINANTSGastroenterologyMachine LearningPathogenesisACTIVATION0302 clinical medicineRisk FactorsPlateletWhole bloodlcsh:R5-920AspirinOUTCOMESThrombinVenous ThromboembolismGeneral MedicineMiddle AgedThrombosisVenous thrombosis030220 oncology & carcinogenesisAcute DiseaseFemaleDisease Susceptibilitylcsh:Medicine (General)Research Papermedicine.drugBlood Plateletsmedicine.medical_specialtyPlatelet Function TestsGeneral Biochemistry Genetics and Molecular BiologyImmunophenotyping03 medical and health sciencesACUTE PULMONARY-EMBOLISMRISK-FACTORInternal medicinemedicineHumansMean platelet volumeMETAANALYSISAgedPlatelet Countbusiness.industrylcsh:RPlatelet Activationmedicine.diseasePREVENTIONASPIRINTHROMBOSIS030104 developmental biologyPlatelet-rich plasmaVOLUMEbusinessBiomarkersEBioMedicine
researchProduct

Is PRP useful in alveolar cleft reconstruction? Platelet-rich plasma in secondary alveoloplasty

2009

Objective: Cleft lip and palate is a congenital facial malformation with an established treatment protocol. Mixed dentition period is the best moment for correct maxillary bone defect with an alveoloplasty. The aim of this surgical procedure is to facilitate dental eruption, re-establish maxillary arch, close any oro-nasal communication, give support to nasal ala, and in some cases allow dental rehabilitation with osteointegrated implants. Study design: Twenty cleft patients who underwent secondary alveoloplasty were included. In 10 of them autogenous bone graft were used and in other 10 autogenous bone and platelet-rich plasma (PRP) obtained from autogenous blood. Bone formation was compar…

MaleBone RegenerationCleft LipDentistryAlveoloplastyMedicineHumansBone formationMixed dentitionBone regenerationChildGeneral DentistryMaxillary archBone Transplantationbusiness.industryPlatelet-Rich PlasmaAlveoloplasty:CIENCIAS MÉDICAS [UNESCO]Combined Modality TherapyNasal alaCleft PalateOtorhinolaryngologyPlatelet-rich plasmaDental eruptionUNESCO::CIENCIAS MÉDICASSurgeryFemalebusiness
researchProduct

Conservative Surgical Treatment of Bisphosphonate-Related Osteonecrosis of the Jaw with Er,Cr:YSGG Laser and Platelet-Rich Plasma: A Longitudinal Stu…

2018

Introduction. The management of bisphosphonate-related osteonecrosis of the jaw (BRONJ), with no evidence-based guidelines, remains controversial. We aimed to evaluate the efficiency of a conservative surgical treatment combining Er,Cr:YSGG laser and platelet-rich plasma (PRP) for the treatment of BRONJ in cancer patients. Methods. We performed a longitudinal cohort study. Inclusion criteria were (1) age ≥ 18 years; (2) cancer diagnosis; (3) treatment with NBP because of the underlying cancer. Results. We consecutively recruited ten patients diagnosed with BRONJ in stage I or II. These patients underwent a surgical laser-assisted therapy together with autologous PRP. At the latest follow-up…

MaleGenetics and Molecular Biology (all)medicine.medical_specialtyLongitudinal studyArticle SubjectImmunology and Microbiology (all)medicine.medical_treatmentSettore MED/19 - Chirurgia Plasticalcsh:MedicineLasers Solid-StateSettore MED/08 - Anatomia PatologicaBiochemistryGeneral Biochemistry Genetics and Molecular BiologySettore MED/01 - Statistica Medica03 medical and health sciences0302 clinical medicineSettore MED/28 - Malattie OdontostomatologichemedicineHumansLongitudinal StudiesProspective StudiesSurgical treatmentProspective cohort studyAgedAged 80 and overSurgical approachBiochemistry Genetics and Molecular Biology (all)Bone Density Conservation AgentsDiphosphonatesGeneral Immunology and MicrobiologyPlatelet-Rich Plasmabusiness.industrylcsh:RCancer030206 dentistryGeneral MedicineBisphosphonatemedicine.diseaseSurgery030220 oncology & carcinogenesisPlatelet-rich plasmaClinical StudyBisphosphonate-Associated Osteonecrosis of the JawFemaleOsteonecrosis of the jawbusinessBiochemistry Genetics and Molecular Biology (all); Immunology and Microbiology (all)
researchProduct

Use of platelet concentrate gel in second-intention wound healing: a case report.

2021

Abstract Background Wound healing is a complex and dynamic process. Healing of acute and chronic wounds can be impaired by patient factors (that is, comorbidities) and/or wound factors (that is, infection). Regenerative medicine products, such as autologous/homologous platelet-rich plasma gel, may speed up the healing process. Autologous/homologous platelet-rich plasma is an advanced wound therapy used for hard-to-heal acute and chronic wounds. The cytokines and growth factors contained in platelet-rich plasma play a crucial role in the healing process. Case presentation A 61-year-old Caucasian male patient, suffering from mental retardation following meningitis, with a transplanted kidney …

MaleMethicillin-Resistant Staphylococcus aureusmedicine.medical_specialtymedicine.drug_classmedicine.medical_treatmentFistulaArteriovenous fistulalcsh:MedicineCase ReportIntention030204 cardiovascular system & hematology030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineAntisepticSurgical oncologymedicineHumansWound Healingintegumentary systembusiness.industryPlatelet-Rich Plasmalcsh:RGranulation tissueGeneral MedicineMiddle Agedmedicine.diseaseSurgerymedicine.anatomical_structureAmputationRegenerative medicineQuality of LifeSkin flapSurgeryWound healingbusinessMeningitisJournal of medical case reports
researchProduct

Autologous Platelet-Rich Plasma in the treatment of androgenetic alopecia: results of a 54-patient prospective study

2021

The current medical treatments of androgenetic alopecia (AGA) have hardly achieved a satisfying clinical improvement. Biologic regenerative therapies, such as platelet-rich plasma (PRP) injections in the scalp, have been proposed recently. This multidisciplinary prospective study aims to explore the efficacy and safety of autologous PRP injections into the scalp of patients with AGA. Fifty-four patients with AGA (35 men and 19 women) were enrolled. Non-activated autologous PRP was injected into the androgen-related areas of the scalp. The study protocol consisted of three sessions of injections at 3-month interval. The effects were assessed by means of noninvasive methods. Safety profile, p…

MalePlatelet-Rich Plasma Autologous PRP Androgenetic Alopecia Woman AGA Man AGA Growth FactorScalpTreatment OutcomePlatelet-Rich PlasmaSettore MED/35 - Malattie Cutanee E VenereeHumansAlopeciaFemaleProspective StudiesHair
researchProduct

Impact of platelet rich plasma and adipose stem cells on lymphangiogenesis in a murine tail lymphedema model.

2015

Abstract Background Lymphedema is an underdiagnosed pathology which in industrialized countries mainly affects cancer patients that underwent lymph node dissection and/or radiation. Currently no effective therapy is available so that patients' life quality is compromised by swellings of the concerned body region. This unfortunate condition is associated with body imbalance and subsequent osteochondral deformations and impaired function as well as with an increased risk of potentially life threatening soft tissue infections. Methods The effects of PRP and ASC on angiogenesis (anti-CD31 staining), microcirculation (Laser Doppler Imaging), lymphangiogenesis (anti-LYVE1 staining), microvascular…

MaleTailPathologymedicine.medical_specialtyAngiogenesisCorrosion CastingMesenchymal Stem Cell TransplantationBiochemistryMicemedicineAnimalsHumansRegenerationLymphedemaLymphangiogenesisLymph nodeLymphatic Vesselsbusiness.industryPlatelet-Rich PlasmaCell Biologymedicine.diseaseLymphangiogenesisMice Inbred C57BLAdult Stem CellsDisease Models Animalmedicine.anatomical_structureLymphedemaLymphatic systemAdipose TissuePlatelet-rich plasmaMicroscopy Electron ScanningBody regionCardiology and Cardiovascular MedicineWound healingbusinessMicrovascular research
researchProduct

Efficacy of platelet-rich plasma applied to post-extraction retained lower third molar alveoli. A systematic review

2013

Dental retentions have a high prevalence among the general population and their removal can involve multiple complications. The use of platelet rich plasma has been proposed in an attempt to avoid these complications, as it contains high growth factors and stimulates diverse biological functions that facilitate the healing of soft and hard tissues. Objectives: To evaluate the available scientific evidence related to the application of platelet-rich plasma in the post-extraction alveoli of a retained lower third molars. Material and Methods: A systematic review of published literature registered in the Medline, EMBASE, Cochrane and NIH databases. The following categories were included: human…

MolarBone densityPopulationDentistryOdontologíalaw.inventionPostoperative ComplicationsRandomized controlled triallawmedicineHumansPlateletTooth SocketeducationGeneral DentistryDental alveoluseducation.field_of_studyPlatelet-Rich Plasmabusiness.industryResearchmedicine.disease:CIENCIAS MÉDICAS [UNESCO]Ciencias de la saludOtorhinolaryngologyPlatelet-rich plasmaUNESCO::CIENCIAS MÉDICASTooth ExtractionMolar ThirdSurgeryOral SurgeryOsteitisbusiness
researchProduct

Clinical Applications, Pitfalls, and Uncertainties of Thrombin Generation in the Presence of Platelets

2019

Platelet-dependent thrombin generation is a helpful tool to assess ex vivo the interaction between platelets and plasma coagulation factors in the initiation, amplification, and inhibition of thrombin generation (TG). This review article discusses the most relevant available data on the clinical applications of fluorogenic TG, the most widely used TG assay, performed in the presence of platelets, i.e., in platelet-rich plasma. With respect to prothrombotic states, arterial hypertension and obesity were the most prominent cardiovascular conditions linked to increased platelet-dependent TG. In addition, platelet-associated hypercoagulability, assessed by the TG assay, has been shown in indivi…

Oncologycardiovascular risk factorsmedicine.medical_specialtyBLEEDING PHENOTYPElcsh:MedicineReview030204 cardiovascular system & hematologyHYPERCOAGULABILITYACTIVATION03 medical and health sciences0302 clinical medicineInternal medicinehemophiliamedicineVon Willebrand diseasePlateletSEVERE HEMOPHILIA-AthrombosisVENOUS THROMBOEMBOLISMRICH PLASMAbiologybusiness.industryCALIBRATED AUTOMATED THROMBOGRAMlcsh:RRECOMBINANT FACTOR VIIAGeneral Medicinemedicine.diseasebleedingThrombosisFACTOR-V DEFICIENCYcardiovascular diseasesBleeding diathesisCoagulationRecombinant factor VIIathrombin generationOBESITYplateletsbiology.proteinBiomarker (medicine)businessvon Willebrand diseaseEx vivo030215 immunologyJournal of Clinical Medicine
researchProduct